Marie Claire Layzell

Title: Marie Claire Layzell: Innovator in Pharmaceutical Formulations

Introduction

Marie Claire Layzell is a prominent inventor based in London, GB. She has made significant contributions to the field of pharmaceutical formulations, holding a total of 10 patents. Her work focuses on innovative injectable and inhalable formulations that have potential applications in treating psychiatric and neurological disorders.

Latest Patents

Layzell's latest patents include groundbreaking injectable formulations. These formulations consist of a salt of an optionally substituted dimethyltryptamine compound, a buffer, and water. They are designed to have pH values ranging from about 3.5 to about 6.5 and osmolalities of about 250 to about 350 mOsm/Kg. Such formulations are stable, clinically acceptable, and suitable for injection. They hold promise for treating various psychiatric or neurological disorders. Additionally, she has developed injectable and inhalable formulations that comprise a salt of an optionally substituted dimethyltryptamine compound and water. These formulations are effective for psychedelic-assisted therapy and can be administered through intramuscular injection or nebulized inhalation.

Career Highlights

Throughout her career, Layzell has worked with notable companies such as Small Pharma Ltd and Cybin UK Ltd. Her innovative approach to pharmaceutical formulations has positioned her as a key player in the industry.

Collaborations

Layzell has collaborated with esteemed colleagues, including Peter Rands and Zelah Joel. Their combined expertise has contributed to the advancement of her research and the successful development of her patents.

Conclusion

Marie Claire Layzell is a trailblazer in the field of pharmaceutical innovations. Her contributions through her patents and collaborations continue to pave the way for advancements in treatments for psychiatric and neurological disorders.